| Value | ₹5.00 Cr |
|---|
BSE filing, NSE: TAKE. Summary written from the filing by ALFA Finder's alert engine.
TAKE Ltd: key numbers
- Share price
- ₹10.96
- Market cap
- ₹162.1 Cr
- Revenue (annual)
- ₹54.19 Cr
- Net profit (annual)
- ₹10.85 Cr
- P/E (TTM)
- 12.7×Sector 52.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TAKE Ltd
All →TAKE Other Announcement
Take Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
TAKE Annual General Meeting
TAKE Limited submitted the proceedings of its 25th Annual General Meeting held on September 29, 2026. The meeting covered routine business, including financial statement adoption and auditor appointments.
TAKE Annual Report
TAKE Limited has submitted its Annual Report for the financial year 2025-26 as per SEBI regulations. The filing includes audited financial statements and relevant corporate reports.
TAKE Annual General Meeting
TAKE Limited will hold its 25th Annual General Meeting on September 29, 2026, via video conferencing. The meeting agenda includes the adoption of financial statements.
TAKE Management Change
TAKE Limited has re-appointed Parmeshvar Dhangare as a Non-Executive Non-Independent Director and appointed M/s. A. Raghavendra Rao & Associates as Statutory Auditor.
TAKE Other Announcement
Take Limited has appointed M/s. Tejas Nadkarni & Associates as Internal Auditor. The appointment is effective for a 12-month term.
Other other announcement announcements
All →NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.
P N Gadgil Jewellers Other Announcement
P N Gadgil Jewellers filed a Monitoring Agency Report on its QIP proceeds for the quarter ended 30 September 2026. The agency reports no deviation from the stated objects of the Rs 7,000 million issue.